tiprankstipranks
Genetron Holdings Ltd (GTH)
NASDAQ:GTH
US Market

Genetron Holdings (GTH) Stock Price & Analysis

33 Followers

GTH Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.08 - $4.00
Previous Close$3.9
Volume5.23K
Average Volume (3M)37.78K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$169.37M
Price to Earnings (P/E)N/A
Beta0.94
May 20, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding30,516,235
10 Day Avg. Volume36,918
30 Day Avg. Volume37,785
Standard Deviation0.21
R-Squared0.01
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)3.05
Price to Sales (P/S)-0.15
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

0.00%0.01%9.97%90.02%
0.00%
Insiders
9.97% Other Institutional Investors
90.02% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

GTH FAQ

What was Genetron Holdings Ltd’s price range in the past 12 months?
Genetron Holdings Ltd lowest stock price was $2.08 and its highest was $4.00 in the past 12 months.
    What is Genetron Holdings Ltd’s market cap?
    Currently, no data Available
    When is Genetron Holdings Ltd’s upcoming earnings report date?
    Genetron Holdings Ltd’s upcoming earnings report date is May 20, 2024 which is in 62 days.
      How were Genetron Holdings Ltd’s earnings last quarter?
      Currently, no data Available
      Is Genetron Holdings Ltd overvalued?
      According to Wall Street analysts Genetron Holdings Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Genetron Holdings Ltd pay dividends?
        Genetron Holdings Ltd does not currently pay dividends.
        What is Genetron Holdings Ltd’s EPS estimate?
        Genetron Holdings Ltd’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Genetron Holdings Ltd have?
        Genetron Holdings Ltd has 31,624,382 shares outstanding.
          What happened to Genetron Holdings Ltd’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Genetron Holdings Ltd?
          Among the largest hedge funds holding Genetron Holdings Ltd’s share is Baker Bros Advisors LP. It holds Genetron Holdings Ltd’s shares valued at N/A.
            ---

            Company Description

            Genetron Holdings Ltd

            Genetron Holdings Ltd is an oncology company in China. It is specialized in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The company generates revenue through precision oncology testing and development services. Precision oncology testing includes the diagnosis and monitoring and early screening performed in the form of LDT services and IVD products. Development services consist of research services and sequencing services.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            TransMedics Group
            BIMI International Medical
            Nano-X Imaging
            Onconova Therapeutics
            Popular Stocks
            ---
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis